Skip to Content

Evarrest Approval History

FDA Approved: Yes (First approved December 5, 2012)
Brand name: Evarrest
Generic name: fibrin sealant
Dosage form: Patch
Company: Ethicon, Inc.
Treatment for: Bleeding Disorder

Evarrest (fibrin sealant patch) is indicated for use with manual compression as an adjunct to hemostasis for problematic soft tissue bleeding during surgery.

Development History and FDA Approval Process for Evarrest

DateArticle
Dec  7, 2012Approval FDA Approves Evarrest Fibrin Sealant Patch

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide